NISHIYAMA Hiroyuki
- Articles
- Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial
Nishiyama Hiroyuki; Yamamoto Yoshiaki; Sassa Naoto; Ni...
International journal of clinical oncology/25(1)/pp.165-174, 2020-01 - Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Petrylak Daniel P; de Wit Ronald; Chi Kim N; Drakaki ...
The Lancet. Oncology/21(1)/pp.105-120, 2020-01 - Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan
Nagumo Yoshiyuki; Kojima Takahiro; Shiga Masanobu; Kojo ...
International journal of urology : official journal of the Japanese Urological Association/27(2)/pp.157-162, 2019-12 - Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence
Ikeda Atsushi; Nosato Hirokazu; Kochi Yuta; Kojima Takah...
Journal of endourology/34(3)/pp.352-358, 2019-12 - A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin (G plus C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA).
Powles Thomas; Meeks Joshua J.; Galsky Matt D.; Van der H...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Bacillus Calmette-Guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction: Phase III KEYNOTE-676 study.
Kamat Ashish M.; Shore Neal D.; Hahn Noah M.; Alanee Sha...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG): Updated follow-up from KEYNOTE-057.
De Wit Ronald; Kulkarni Girish S.; Uchio Edward M.; Krieg...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
Nitta Satoshi; Tsutsumi Masakazu; Sakka Shotaro; Endo Ts...
PROSTATE INTERNATIONAL/7(3)/pp.114-118, 2019-09 - A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
Nagumo Yoshiyuki; Kojima Takahiro; Shiga Masanobu; Kan...
International journal of clinical oncology/25(2)/pp.354-361, 2020-02 - A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
Yoshiyuki Nagumo; Takahiro Kojima; Masanobu Shiga; Shuya ...
Int J Clin Oncol/25(2)/pp.354-361, 2019-10 - Updated Interim Analysis from Keynote-057: Pembrolizumab Monotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Krieger Laurence; de Wit Ronald; Kulkarni Girish S.; U...
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY/15(4:SI)/pp.52-53, 2019-07 - Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Kuroiwa Kentaro; Inokuchi Junichi; Nishiyama Hiroyuki; Ko...
The Journal of urology/202(6)/pp.1127-1134, 2019-06 - Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
Mishima Saori; Taniguchi Hiroya; Akagi Kiwamu; Baba Eish...
International journal of clinical oncology/Epub, 2019-07 - Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer
Nitta Satoshi; Kawai Koji; Nagumo Yoshiyuki; Kandori Shu...
Japanese journal of clinical oncology/49(12)/pp.1151-1156, 2019-07 - A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients
Sanada Yuko; Harada Miyuki; Kunitomi Chisato; Kanatani...
The journal of obstetrics and gynaecology research/45(10)/pp.2021-2028, 2019-07 - TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
Kawahara Takashi; Kojima Takahiro; Kandori Shuya; Kurobe ...
PloS one/14(8), 2019-04 - 尿路上皮がん１）尿路上皮がんに対する分子標的約の開発動向
河原貴史; 西山 博之
腫瘍内科/28(1)/pp.37-41, 2019-01 - 【MSI-H Cancerの診断と治療】 泌尿器科領域におけるMSI-H Cancerの診断と治療
河原貴史; 西山 博之
"癌と化学療法 "/45(11)/pp.1573-1576, 2018-11 - 【風雲!膀胱がんの診断・治療】 ウロビジョンDNA FISHプローブキット TUR後フォローアップはどう変わるのか?(
小島崇宏; 池田篤史; 西山 博之
泌尿器外科/31(9)/pp.1275-1280, 2018-09 - "【エキスパートが本音で語る! 膀胱癌診療の最前線】膀胱癌診断の最前線 ウロビジョンを用いたNMIBCの新たなフォローアップ戦略 "
小島崇宏; 池田 篤史; 西山 博之
臨床泌尿器科/72(7), 2018-06 - Current status of Human tissue Biobank —Biobanks in Europe and Japan—
竹内 朋代; 大和田洋平; 宮崎貴寛; 小田竜也; 武川 寛樹; 西山博之; 大河内信弘
Organ Biology/26(1)/pp.43-49, 2019 - Multidisciplinary approach to kidney transplant -Tsukuba style-
高橋 一広; 金子 修三; 臼井 丈一; 福田 将一; 木村 友和; 星 昭夫; 小田 竜也; 西山 博之; キム ディーン; パ...
移植/pp.383-383, 2018-09 - 筑波大学附属病院における腎移植医療の取り組みーコーディネーターの位置づけと課題ー
福田 将一; 高橋 一広; 金子 修三; 臼井 丈一; 木村 友和; 星 昭夫; 梶山 陽子; 小泉 仁子; 小田 竜也; 湯沢 ...
移植/53/pp.359-359, 2018-09 - ウロビジョンを用いたNMISCの新たなフォローアップ戦略
小島 崇宏; 池田 篤史; 西山 博之
泌尿器外科/32(4)/pp.400-403, 2019-05 - Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus
Hayami Hiroshi; Takahashi Satoshi; Ishikawa Kiyohito; ...
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy/25(6)/pp.413-422, 2019-03 - more...
- Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial